You are here
Breast-Cancer Patients Under 40 May Keep Fertility With Drug, Study Finds
Younger women with early-stage breast cancer who took a drug to suppress their ovaries were more likely to avert early menopause caused by chemotherapy, researchers found. The treatment, triptorelin, helped patients avoid the permanent loss of their fertility that can be prompted by chemotherapy’s toxic doses, according to research published in the Journal of the American Medical Association. Doctors diagnose almost 25,000 women younger than 45 with breast cancer every year, wrote Hope Rugo and Mitchell Rosen of the University of California, San Francisco, in an accompanying editorial.